An update from China NT Pharma Group Co., Ltd. ( (HK:1011) ) is now available.
China NT Pharma Group Co., Ltd. has announced the despatch of a Circular related to a connected transaction involving loan capitalization and subscription of shares under a specific mandate. This includes an application for a Whitewash Waiver and a notice of an Extraordinary General Meeting (EGM). The completion of the subscription is contingent upon the fulfillment of certain conditions, including the granting of the Whitewash Waiver by the Executive and approval by independent shareholders. Shareholders and investors are advised to exercise caution in dealings.
More about China NT Pharma Group Co., Ltd.
YTD Price Performance: -7.41%
Average Trading Volume: 226,965
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: HK$63.31M
For an in-depth examination of 1011 stock, go to TipRanks’ Stock Analysis page.